Isotretinoin: state of the art treatment for acne vulgaris

References

• Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J. Am. Acad. Dermatol.41, 577–580 (1999).
   PubMed Web of Science ®Google Scholar
• Zouboulis C. Retinoids: is there a new approach? IFSCC Magazine3(3), 9–19 (2000).
   Google Scholar
• Kuenzli S, Saurat J-H. Retinoids. In: Dermatology (Volume 2). Bolognia JL, Jorizzo JL, Rapini RP (Eds). Mosby, London, UK, 1991–1996 (2003).
   Google Scholar
• Benifla JL, Ville Y, Imbert MC, Frydman R, Thomas A, Pons JC. Fetal tissue dosages of retinoids: experimental study concerning a case of isotretinoin (Roaccutan) administration and pregnancy. Fetal Diagn. Ther.10, 189–191 (1995).
   PubMedGoogle Scholar
• Matsuoka LY, Wortsman J, Tang G et al. Are endogenous retinoids involved in the pathogenesis of acne? Arch. Dermatol.127, 1072–1073 (1991).
   Google Scholar
• Blaner WS, Olson JA. Retinol and retinoic acid metabolism. In: The Retinoids. Biology, Chemistry, and Medicine (3rd Edition). Raven Press, NY, USA, 229–256 (1994).
   Google Scholar
• Rollmann O, Vahlquist A. Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: drug and vitamin A concentrations in serum and skin. J. Invest. Dermatol.86, 384–389 (1986).
   Google Scholar
• Roos TC, Jugert FK, Merk HF, Bickers DR. Retinoid metabolism in the skin. Pharm. Rev.50, 315–333 (1998).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC. Exploration of retinoid activity and the role of inflammation in acne: issues affecting future directions for acne therapy J. Eur. Acad. Dermatol. Venereol.15, 63–67 (2001).
   PubMed Web of Science ®Google Scholar
• Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology196, 140–147 (1998).
   PubMed Web of Science ®Google Scholar
• Kistler A. Limb bud cell cultures for estimating the teratogenic potential of compounds: validation of the test system with retinoids. Arch. Toxicol.60, 403–414 (1987).
   PubMed Web of Science ®Google Scholar
• Orfanos CE, Zouboulis CC, Almond-Roesler B, Geilen CC. Current use and future potential role of retinoids in dermatology. Drugs53, 358–388 (1997).
   PubMed Web of Science ®Google Scholar
• Landthaler M, Kummermehr J, Wagner A, Plewig G. Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands. Arch. Dermatol. Res.269, 297–309 (1980).
   PubMed Web of Science ®Google Scholar
• Melnik B, Kinner T, Plewig G. Influence of oral isotretinoin treatment on the composition of comedonal lipids. Implications for comedogenesis in acne vulgaris. Arch. Dermatol. Res.280, 97–102 (1988).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Krieter A, Gollnick H, Orfanos CE. Progressive differentiation of human sebocytes in vitro is characterized by increased cell size and altered antigenic expression and is regulated by culture duration and retinoids. Exp. Dermatol.3, 151–160 (1994).
   PubMedGoogle Scholar
• Zouboulis CC, Korge B, Akamatsu H et al. Effects of 13-cis-retinoic acid, all-trans-retinoic acid and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J. Invest. Dermatol.96, 792–797 (1991).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Xia L, Korge B, Gollnick H, Orfanos CE. Cultivation of human sebocytes in vitro: cell characterization and influence of synthetic retinoids. In: Retinoids: 10 Years On. Saurat J-H (Ed.). Karger, Basel, Switzerland, 254–273 (1991).
   Google Scholar
• Geiger JM. Retinoids and sebaceous gland activity. Dermatology191, 305–310 (1995).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology206, 37–53 (2003).
   Google Scholar
• King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br. J. Dermatol.107, 583–590 (1982).
   PubMed Web of Science ®Google Scholar
• Adams J, Kiss E, Arroyo ABV et al. 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am. J. Pathol.167, 285–298 (2005).
   Google Scholar
• Zouboulis CC. Retinoids – which dermatological indications will benefit in the near future? Skin Pharmacol. Appl. Skin Physiol.14, 303–315 (2001).
   PubMedGoogle Scholar
• Zouboulis CC. Isotretinoin revisited – pluripotent effects on human sebaceous gland cells. J. Invest. Dermatol.126, 2154–2156 (2006).
   PubMed Web of Science ®Google Scholar
• Tsukada M, Schröder M, Roos TC et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J. Invest. Dermatol.115, 321–327 (2000).
   PubMed Web of Science ®Google Scholar
• Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J. Invest. Dermatol.126, 2178–2189 (2006).
   PubMed Web of Science ®Google Scholar
• Kang S, Cho S, Chung JH et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-κB and activator protein-1 in inflammatory acne lesions in in vivo. Am. J. Pathol.166, 1691–1699 (2005).
   PubMed Web of Science ®Google Scholar
• Papakonstantinou E, Aletras AJ, Glass E et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J. Invest. Dermatol.125, 673–684 (2005).
   PubMed Web of Science ®Google Scholar
• Guy R, Ridden C, Kealey T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J. Invest. Dermatol.106, 454–460 (1996).
   PubMed Web of Science ®Google Scholar
• Karlsson T, Vahlquist A, Kedishvili N, Torma H. 13-cis-retinoic acid competitively inhibits 3 α-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochem. Biophys. Res. Commun.303, 273–278 (2003).
   PubMedGoogle Scholar
• Zouboulis CC, Korge B, Mischke D, Orfanos CE. Altered proliferation, synthetic activity, and differentiation of cultured human sebocytes in the absence of Vitamin A and their modulation by synthetic retinoids. J. Invest. Dermatol.101, 628–633 (1993).
   PubMed Web of Science ®Google Scholar
• Downie MMT, Sanders DA, Kealey T. Modelling the remission of individual acne lesions in vitro. Br. J. Dermatol.147, 869–878 (2002).
   PubMed Web of Science ®Google Scholar
• Norris DA, Osborn R, Robinson W, Tonnesen MG. Isotretinoin produces significant inhibition of monocyte and neutrophil chemotaxis in vivo in patients with cystic acne. J. Invest. Dermatol.89, 38–43 (1987).
   PubMed Web of Science ®Google Scholar
• Orfanos CE, Bauer R. Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br. J. Dermatol.109, 55–60 (1983).
   PubMed Web of Science ®Google Scholar
• Goldman R. Effect of retinoic acid on the proliferation and phagocytic capability of murine macrophage-like cell lines. J. Cell. Physiol.120, 91–102 (1984).
   Google Scholar
• Holland DB, Jeremy AH, Roberts SG et al. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br. J. Dermatol.150, 72–81 (2004).
   PubMed Web of Science ®Google Scholar
• Bécherel PA, Mossalayi MD, Le Goff L et al. Mechanism of anti-inflammatory action of retinoids on keratinocytes. Lancet344, 1570–1571 (1994).
   Google Scholar
• Boman HG. Gene-encoded peptide antibiotics and the concept of innate immunity: an update review. Scand. J. Immunol.48, 15–25 (1998).
   PubMed Web of Science ®Google Scholar
• Zanetti M, Litteri L, Gennaro R, Horstmann H, Romeo D. Bactenecins, defense polypeptides of bovine neutrophils are generated from precursor molecules stored in the large granules. J. Cell. Biol.111, 1363–1371 (1990).
   PubMed Web of Science ®Google Scholar
• Frohm M, Agerberth B, Ahangari G et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem.272, 15258–15263 (1997).
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang G, Minton JE et al. Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection. Infect. Immun.68, 5552–5558 (2000).
   PubMed Web of Science ®Google Scholar
• Layton AM, Dreno B, Gollnick HPM, Zouboulis CC. A review of the European directive for prescribing systemic isotretinoin for acne vulgaris. J. Eur. Acad. Dermatol. Venereol.20, 773–776 (2006).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC. Acne: current aspects on pathology and treatment. Dermatol. Experiences1, 6–37 (1999).
   Google Scholar
• Zouboulis CC, Orfanos CE. Retinoids. In: Drug Therapy in Dermatology. Millikan LE (Ed.). Marcel Dekker, NY, USA, 171–233 (2000).
   Google Scholar
• Caputo R, Cavicchini S, Cooper A et al. Roaccutane treatment guidelines: results of an international survey. Dermatology194, 351–357 (1997).
   Google Scholar
• Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J. Am. Acad. Dermatol.27, S2–S7 (1992).
   PubMed Web of Science ®Google Scholar
• Seukeran DC, Cunliffe WJ. Acne vulgaris in the elderly: the response to low-dose isotretinoin. Br. J. Dermatol.139, 99–101 (1998).
   PubMed Web of Science ®Google Scholar
• Georgarakis M, Zougrou F, Tzavara S, Kontopoulos G, Tsiptsios I. Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteers. Int. J. Clin. Pharmacol. Therapeutics41, 316–322 (2003).
   Google Scholar
• Taylor PW, Keenan MHJ. Pharmaceutical quality of generic isotretinoin products, compared with Roaccutane. Cur. Med. Res. Opin.22, 603–615 (2006).
   PubMed Web of Science ®Google Scholar
• James WD. Acne. N. Engl. J. Med.352, 1463–1472 (2005).
   PubMed Web of Science ®Google Scholar
• Layton AM. A review on the treatment of acne vulgaris. Int. J. Clin. Pract.60, 64–72 (2006).
   PubMed Web of Science ®Google Scholar
• Stainford JM, Layton AM, Taylor JP et al. Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br. J. Dermatol.129, 297–301 (1993).
   Google Scholar
• Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris – 10 years later: a safe and successful treatment. Br. J. Dermatol.129, 292–296 (1993).
   PubMed Web of Science ®Google Scholar
• Goulden V, Clark SM, McGeown C et al. Treatment of acne with intermittent isotretinoin. Br. J. Dermatol.137, 106–108 (1997).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC. The truth behind this undeniable efficacy – recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology212, 99–100 (2006).
   PubMed Web of Science ®Google Scholar
• Mitchell AA, Van Bennekom CM, Louik C. A pregnancy-prevention program in women of childbearing age receiving isotretinoin. N. Engl. J. Med.333, 101–106 (1995).
   PubMed Web of Science ®Google Scholar
• Wessels F, Anderson AN, Kropman K. The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model. S. Afr. Med. J.89, 791–794 (1999).
   PubMedGoogle Scholar
• Newton JN. How cost-effective is oral isotretinoin? Dermatology195, 38–40 (1997).
   Google Scholar
• Lee ML, Cooper A. Isotretinoin: cost-benefit study. Australas. J. Dermatol.32, 17–20 (1991).
   PubMedGoogle Scholar
• Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J. Am. Acad. Dermatol.45, 150–157 (2001).
   PubMed Web of Science ®Google Scholar
• Goulden V, Layton AM, Cunliffe WJ. Longterm safety of isotretinoin as a treatment for acne vulgaris. Br. J. Dermatol.131, 360–363 (1994).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia arreata, atopic dermatitis and psoriasis. Br. J. Dermatol.139, 846–850 (1998).
   PubMed Web of Science ®Google Scholar
• Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch. Dermatol.136, 1231–1236 (2000).
   PubMedGoogle Scholar
• Rubinow DR, Peck GL, Squillace KM, Gantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J. Am. Acad. Dermatol.17, 25–32 (1987).
   PubMed Web of Science ®Google Scholar
• Ng CH, Schweitzer I. The association between depression and isotretinoin use in acne. Aust. NZ J. Psychiatry37, 78–84 (2003).
   PubMed Web of Science ®Google Scholar
• De Marchi MA, Maranhao RC, Brandizzi LI, Souza DR. Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne. Arch. Dermatol. Res.297, 403–408 (2006).
   PubMed Web of Science ®Google Scholar
• Ethan-Quan HN, Wolverton S. Systemic retinoids. In: Comprehensive Dermatology Drug Therapy. Wolverton SE (Ed.). WB Sauders, PA, USA, 269–310 (2001).
   Google Scholar
• Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol.132, 299–305 (2001).
   PubMed Web of Science ®Google Scholar
• Ling TC, Parkin G, Islam J et al. What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH? Br. J. Dermatol.144, 630–632 (2001).
   PubMed Web of Science ®Google Scholar
• Liebler S, Uberschar B, Kubert H et al. Renal retinoid system: time-dependent activation in experimental glomerulonephritis. Am. J. Physiol. Renal. Physiol.286, F458–F465 (2004).
   Google Scholar
• Zouboulis CC, Eady A, Philpott M et al. What is the pathogenesis of acne? Exp. Dermatol.14, 143–152 (2005).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC. Therapie der Akne mit Antiandrogenen – Eine evidenzbasierte Übersicht. J. Dtsch. Dermatol. Ges.1, 535–546 (2003).
   PubMedGoogle Scholar
• Zouboulis CC, Nestoris S, Adler YD et al.A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch. Dermatol.139, 668–670 (2003).
   PubMed Web of Science ®Google Scholar
• Zouboulis CC, Saborowski A, Boschnakow A. Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology210, 36–38 (2005).
   PubMed Web of Science ®Google Scholar
• Nagy I, Pivarcsi A, Kis K et al.Propionibacterium acnes and lipopolysaccharide induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect.8, 2195–2205 (2006).
   PubMed Web of Science ®Google Scholar
• Lee D-Y, Yamasaki K, Zouboulis CC et al.Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J. Invest. Dermatol.(2007) (In Press).
   Google Scholar
• Thielitz A, Reinhold D, Vetter R et al. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) target major pathogenetic steps in acne initiation. J. Invest. Dermatol.127, 1042–1051 (2007).
   PubMed Web of Science ®Google Scholar
• Hong I, Lee M-H, Na T-Y et al. LXRα enhances lipid synthesis in SZ95 sebocytes. J. Invest. Dermatol(2007) (In Press).
   Google Scholar
• Georgel P, Crozat K, Lauth X et al. A TLR2-responsive lipid effector pathway protects mammals against Gram-positive bacterial skin infections. Infect. Immun.73, 4512–4521 (2005).
   PubMed Web of Science ®Google Scholar
• Alestas T, Ganceviciene R, Fimmel et al. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J. Mol. Med.84, 75–87 (2006).
   PubMed Web of Science ®Google Scholar